The Public Health Impact of Coccidioidomycosis in Arizona and California

@inproceedings{Hector2011ThePH,
  title={The Public Health Impact of Coccidioidomycosis in Arizona and California},
  author={Richard F. Hector and George W. Rutherford and Clarisse A. Tsang and Laura M. Erhart and Orion McCotter and Shoana Miller Anderson and Kenneth Komatsu and Farzaneh Tabnak and Duc J. Vugia and Ying Chuan Yang and John N. Galgiani},
  booktitle={International journal of environmental research and public health},
  year={2011}
}
The numbers of reported cases of coccidioidomycosis in Arizona and California have risen dramatically over the past decade, with a 97.8% and 91.1% increase in incidence rates from 2001 to 2006 in the two states, respectively. Of those cases with reported race/ethnicity information, Black/African Americans in Arizona and Hispanics and African/Americans in California experienced a disproportionately higher frequency of disease compared to other racial/ethnic groups. Lack of early diagnosis… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 47 CITATIONS

The Rise of Valley Fever: Prevalence and Cost Burden of Coccidioidomycosis Infection in California

  • International journal of environmental research and public health
  • 2019
VIEW 3 EXCERPTS
CITES METHODS, BACKGROUND & RESULTS

Screening Coccidioides serology in kidney transplant recipients: A 10-year cross-sectional analysis.

  • Transplant infectious disease : an official journal of the Transplantation Society
  • 2018

References

Publications referenced by this paper.
SHOWING 1-10 OF 84 REFERENCES

Coccidioidomycosis in African Americans.

  • Mayo Clinic proceedings
  • 2011
VIEW 2 EXCERPTS

Sacramento, CA, USA, July 2007

RaceEthnic Population with Age, 2000–2050 Sex Detail, Department of Finance State of California
  • Available online: http://www.dof.ca.gov/research/ demographic/data/race-ethnic/2000-50/
  • 2011
VIEW 1 EXCERPT

Coccidioidomycosis in patients with HIV-1 infection in the era of potent antiretroviral therapy.

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2010
VIEW 1 EXCERPT

Pharmacokinetics and Safety of Nikkomycin Z Following Multiple Rising Doses in Healthy Subjects

D. E. Nix, S. E. Hoover, +3 authors J. N. Galgiani
  • In Proceedings of the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC),
  • 2010
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…